Literature DB >> 10536205

Modification of acetylcholine release by nociceptin in conscious rat striatum.

K Itoh1, H Konya, E Takai, H Masuda, K Nagai.   

Abstract

Nociceptin (NOC), an endogenous ligand for the orphan opioid receptor ORL1 (ORL1), has recently been recognized as a neuropeptide. We used brain microdialysis and on-line high performance liquid chromatography (HPLC) to examine the effect of NOC on the basal outflow of acetylcholine (ACh) in the freely moving rat striatum in vivo. ACh release was reduced by nociceptin at a concentration of 10(-5) M to 79% of control release. This effect of NOC was attenuated by [Phe1Psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 (PhePsi), suggesting that NOC activates the ORL1 receptor and (PhePsi) acts as an antagonist on ORL1 in rat striatum in vivo. These findings indicate that NOC may act as a neuropeptide which inhibits ACh release in the striatum via ORL1.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10536205     DOI: 10.1016/s0006-8993(99)01954-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

Review 1.  The role of orphanin FQ/nociceptin in neuroplasticity: relationship to stress, anxiety and neuroinflammation.

Authors:  Elyse M Mallimo; Alexander W Kusnecov
Journal:  Front Cell Neurosci       Date:  2013-10-08       Impact factor: 5.505

2.  Genetic dissection of medial habenula-interpeduncular nucleus pathway function in mice.

Authors:  Yuki Kobayashi; Yoshitake Sano; Elisabetta Vannoni; Hiromichi Goto; Hitomi Suzuki; Atsuko Oba; Hiroaki Kawasaki; Shigenobu Kanba; Hans-Peter Lipp; Niall P Murphy; David P Wolfer; Shigeyoshi Itohara
Journal:  Front Behav Neurosci       Date:  2013-03-12       Impact factor: 3.558

Review 3.  A systematic review of the role of the nociceptin receptor system in stress, cognition, and reward: relevance to schizophrenia.

Authors:  Muhammad Saad Khan; Isabelle Boileau; Nathan Kolla; Romina Mizrahi
Journal:  Transl Psychiatry       Date:  2018-02-02       Impact factor: 6.222

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.